HOME >> MEDICINE >> NEWS
Dietary fats may increase the risk of age-related macular degeneration

CHICAGO High intake of dietary fats may increase the risk of progression of age-related macular degeneration, according to an article in the December issue of The Archives of Ophthalmology, one of the JAMA/Archives journals.

According to information in the article, age-related macular degeneration (AMD, a common, progressive eye disease in older people that causes blindness) is the leading cause of irreversible visual impairment and blindness in the United States and in other developed countries. Six percent to eight percent of people aged 75 and older have the advanced stages of AMD associated with blindness. It is estimated that more than eight million people have the intermediate stages of AMD, and of these about 1.3 million people will develop advanced AMD within the next five years.

Johanna M. Seddon, M.D., Sc.M., of the Massachusetts Eye and Ear Infirmary, Boston, and colleagues evaluated the associated between dietary fat intake, including specific types of fat, on rates of progression of AMD in a large population at risk for vision loss.

The researchers studied 261 patients aged 60 or older who had some sign of AMD in at least one eye. Participants were followed for an average of 4.6 years and completed food frequency questionnaires designed to measure the amounts and kinds of foods eaten in the previous week.

The researchers found that consumption of dietary fats and fat-containing food groups modified the risk of progression to advanced AMD, whereas fish and nut consumption reduced the risk.

"In this prospective longitudinal study, we found that higher levels of dietary fat intake were associated with the progression of AMD to the advanced stages associated with visual loss," the authors write. "Specifically, higher intake of vegetable fat, and to a lesser extent animal fat, increased rates of progression. Saturated, monounsaturated, polyunsaturated and transunsaturated fats were also related to progression.
'"/>

Contact: Mary Leach
617-573-4170
JAMA and Archives Journals
8-Dec-2003


Page: 1 2

Related medicine news :

1. National Academies Advisory: April 1 Public Briefing on Safety of Dietary Supplements
2. Dietary supplements containing ephedra and caffeine may cause heart problems
3. Dietary fat not linked to risk of stroke
4. Dietary supplement and flu vaccines
5. Dietary intake of vitamin E may reduce risk of Parkinsons disease
6. Dietary change may prevent the most serious form of prostate cancer
7. Dietary whole grains may benefit in prevention and treatment of type 2 diabetes
8. Examining The Science Behind Nutraceuticals: Proceedings of the AAPS Dietary Supplements Forum
9. American Association of Pharmaceutical Scientists Dietary Supplements Forum examines science behind nutraceuticals
10. Dietary bioflavonoids induce DNA breaks, may contribute to infant leukemia
11. First Evidence Found Of Link Between Gum Disease And High Alcohol Consumption, Low Dietary Antioxidants

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Dietary fats may increase the risk age related macular degeneration

(Date:10/31/2014)... Monica Williams-Murphy MD , advanced care ... the chaos that can occur for people who have ... of Americans who come into the emergency department facing ... for the moment and so are their families." She ... a catalyst for a family to get the critical ...
(Date:10/31/2014)... With all the preparations families carry ... they may overlook one critical area – the potential ... school performance and even behavior. Typical children’s vision screenings ... progressive vision problems, and to address this challenge, Dr. ... initiative: The Awesome Eyes Student Vision Program. , ...
(Date:10/31/2014)... 2014 (HealthDay News) -- Surgery for low back pain ... the United States you live, a new report says. ... back pain at some point in their lives, and ... care for a spine problem," co-author Brook Martin, of ... said in a college news release. In spinal ...
(Date:10/31/2014)... In terms of duration of treatment and cost, ... from accelerated partial breast irradiation (APBI) with proton ... new research from The University of Texas MD ... a cost analysis study based on typical patient ... allowable charges for eight different types of partial ...
(Date:10/31/2014)... lab device to give cancer researchers an unprecedented microscopic ... spread through the body, causing more than 90 percent ... tumor cells travel, the device could uncover new ways ... the university,s Whiting School of Engineering and its Institute ... new system recently in the journal Cancer Research ...
Breaking Medicine News(10 mins):Health News:This Thanksgiving or Christmas Family Gathering, Use The New App ListStuffFast to Start "The Conversation" With a Parent That Has No Plan For End-of-Life 2Health News:This Thanksgiving or Christmas Family Gathering, Use The New App ListStuffFast to Start "The Conversation" With a Parent That Has No Plan For End-of-Life 3Health News:New School Vision Initiative Announced by Dr. Rosenak’s Optical Options; Program Aims to Help Recognize Unseen Vision Problems That Impact School Success 2Health News:New School Vision Initiative Announced by Dr. Rosenak’s Optical Options; Program Aims to Help Recognize Unseen Vision Problems That Impact School Success 3Health News:Spinal Surgery Varies by Region in U.S.: Study 2Health News:Proton therapy shown to be less costly than some alternative radiotherapy techniques 2Health News:Proton therapy shown to be less costly than some alternative radiotherapy techniques 3Health News:Viewing cancer on the move: New device yields close-up look at metastasis 2Health News:Viewing cancer on the move: New device yields close-up look at metastasis 3
(Date:10/31/2014)... Investor-Edge has initiated coverage on the ... Laboratories (NYSE: ABT ), Hologic Inc. (NASDAQ: ... and Covidien PLC (NYSE: COV). Free research on these five ... The US markets on Thursday, October 30, 2014, ended on ... at 17,195.42, up 1.30% and the NASDAQ Composite closed at ...
(Date:10/31/2014)...  Australian biopharmaceutical company Specialised Therapeutics Australia (STA) is ... in combination with gemcitabine, will be reimbursed via the ... cancer from 1 November. In ... th most common cause of cancer mortality. Pancreatic ... the lowest 5-year survival of all common cancers at ...
(Date:10/31/2014)... 31, 2014 Today, Analysts Review ... CELG ), Bristol-Myers Squibb Co. (NYSE: ... ), Sanofi SA (NYSE: SNY ) and ... notes ahead of publication. To reserve complementary membership, limited ... ,Celgene Corporation Research Reports ,On October 23, 2014, Celgene ...
Breaking Medicine Technology:Health Care Equipment Stocks Technical Insight - Medtronic, Abbott Laboratories, Hologic, ResMed, and Covidien 2Health Care Equipment Stocks Technical Insight - Medtronic, Abbott Laboratories, Hologic, ResMed, and Covidien 3Health Care Equipment Stocks Technical Insight - Medtronic, Abbott Laboratories, Hologic, ResMed, and Covidien 4Health Care Equipment Stocks Technical Insight - Medtronic, Abbott Laboratories, Hologic, ResMed, and Covidien 5Specialised Therapeutics Australia Announces Breakthrough Cancer Drug Abraxane(R) to be PBS Listed for Metastatic Pancreatic Cancer 2Specialised Therapeutics Australia Announces Breakthrough Cancer Drug Abraxane(R) to be PBS Listed for Metastatic Pancreatic Cancer 3Specialised Therapeutics Australia Announces Breakthrough Cancer Drug Abraxane(R) to be PBS Listed for Metastatic Pancreatic Cancer 4Specialised Therapeutics Australia Announces Breakthrough Cancer Drug Abraxane(R) to be PBS Listed for Metastatic Pancreatic Cancer 5Specialised Therapeutics Australia Announces Breakthrough Cancer Drug Abraxane(R) to be PBS Listed for Metastatic Pancreatic Cancer 6Specialised Therapeutics Australia Announces Breakthrough Cancer Drug Abraxane(R) to be PBS Listed for Metastatic Pancreatic Cancer 7Specialised Therapeutics Australia Announces Breakthrough Cancer Drug Abraxane(R) to be PBS Listed for Metastatic Pancreatic Cancer 8Financial Results, Acquisition Agreement, and Legal Issue Update - Research Reports on Celgene, Bristol-Myers, UnitedHealth, Sanofi and Actavis 2Financial Results, Acquisition Agreement, and Legal Issue Update - Research Reports on Celgene, Bristol-Myers, UnitedHealth, Sanofi and Actavis 3Financial Results, Acquisition Agreement, and Legal Issue Update - Research Reports on Celgene, Bristol-Myers, UnitedHealth, Sanofi and Actavis 4Financial Results, Acquisition Agreement, and Legal Issue Update - Research Reports on Celgene, Bristol-Myers, UnitedHealth, Sanofi and Actavis 5Financial Results, Acquisition Agreement, and Legal Issue Update - Research Reports on Celgene, Bristol-Myers, UnitedHealth, Sanofi and Actavis 6
Cached News: